Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F6SU3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,869
Award facts
- Contract value 100% obligated
- $10,869.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on February 4, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides Advair HFA 230-21 microgram inhalers (12 grams) with a ceiling value of $10,869.04. The order represents a firm fixed-price purchase under a non-set-aside, competitively awarded contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen, operating as a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in providing prescription medications, medical devices, and specialized healthcare commodities to federal government agencies. The Defense Logistics Agency Medical Supply Chain relies on AmerisourceBergen's extensive distribution network and product portfolio to fulfill critical pharmaceutical procurement needs for military treatment facilities and veteran healthcare programs. This delivery order for respiratory medication aligns with the company's demonstrated capability to efficiently manage federal medical supply requirements across multiple therapeutic domains through established firm fixed-price contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26F6SU3?
SPE2DR26F6SU3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F6SU3 worth?
The government has obligated $10,869 on SPE2DR26F6SU3.
Is contract SPE2DR26F6SU3 an order under another contract?
Yes. SPE2DR26F6SU3 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SU3 competed?
The extent of competition for SPE2DR26F6SU3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award